Company intelligence / Profile preview

FDS Amplicare

New York, New York, United Statespages.nist.gov ↗

Ownership: Public · FDS
Development stage: Commercial

Overview

FDS Amplicare provided cloud-based software solutions enabling pharmacists and pharmacies to schedule, document, and manage clinical services at scale. The company focused on improving pharmacy efficiency and patient outcomes through business intelligence analytics, claims billing support, reporting tools, data synchronization services, and support for expanding clinical care offerings such as immunizations or COVID-19 testing. In July 2021 it was acquired by Omnicell.

Industry: Biomedical IT and Biomedical Data Platforms

Financials

Market cap: $10.3B
Total revenue: $622.9M
Enterprise value: $11.5B

Beyond the preview

Go deeper on FDS Amplicare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FDS Amplicare.

Explore the full profile